Major Extremity Trauma Research Consortium
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Major Extremity Trauma Research Consortium sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).
Major Extremity Trauma Research Consortium: 30 sponsored US clinical trials, 7 recruiting.
Major Extremity Trauma Research Consortium sponsors 30 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 21 completed. 9 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Post Operative Surgical Site Infection, with 3 trials.
Top-decile sponsor footprint
Major Extremity Trauma Research Consortium ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
30 total, page 1 of 1
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
NCT06337292
Evaluation of the Diagnostic and Therapeutic Value of Tissue Ultrafiltration in Patients at Risk of Acute Compartment Syndrome (ACS)
NCT05889559
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
NCT04789044
PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation
NCT05699174
Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.
NCT04839497
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
NCT07006675
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT
NCT04678154
Effects of Early Weight Bearing on Rehabilitation Outcomes in Patients With Traumatic Ankle and Tibial Plateau Fractures
NCT04028414
Rehabilitation Enhanced by Partial Arterial Inflow Restrictions
NCT02746458
Serum-Protein-Based Indices for the Progression of Fracture Healing and Nonunion
NCT05143476
Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA
NCT04597008
Patient-Specific Precision Injury Signatures in Multiply Injured Orthopaedic Patients
NCT03772730
Early Advanced Weight Bearing for Peri-articular Knee and Pilon Injuries
NCT03562364
The Mobility Toolkit: Electronically Augmented Assessment of Functional Recovery Following Lower-extremity Trauma
NCT04047030
Improving Recovery After Orthopaedic Trauma: Cognitive-Behavioral Based Physical Therapy (CBPT)
NCT03335657
PREVENTion of Clot in Orthopaedic Trauma
NCT02984384
Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma
NCT02718768
Prosthetic Fit Assessment in Transtibial Amputees Secondary to Trauma
NCT02540681
Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)
NCT02227446
PRIORITI-MTF Study- Testing Patient Response to the IDEO
NCT02158884
Streamlining Trauma Research Evaluation With Advanced Measurement
NCT02079714
Randomized Trial to Assess PO Versus IV Antibiotics
NCT01714596
Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)
NCT01789216
Improving Activity and Quality of Life Following Orthopaedic Trauma: The Trauma Collaborative Care Study (TCCS)
NCT01907893
Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery
NCT01798810
Transtibial Amputation Outcomes Study
NCT01821976
Predicting Acute Compartment Syndrome (PACS)
NCT01561261
Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol
NCT01606501
Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage
NCT01496014
Assessment of Fixation Strategies for Severe Open Tibia Fractures
NCT01494519
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 9 |
Where Major Extremity Trauma Research Consortium enrollment is open (later-stage tilt)
7 recruiting of 30 indexed (23% open); 21 completed (70%).
Phase mix: 9 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Post Operative Surgical Site Infection (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Major Extremity Trauma Research Consortium: open-pipeline peers nationwide
Peers matched on 30 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Major Extremity Trauma Research Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 30 trials (± recruiting share)
- Biotronik · 30 trials · 3% recruiting
- Charles Drew University of Medicine and Science · 30 trials · 3% recruiting
- Chiesi Farmaceutici S.p.A. · 30 trials · 13% recruiting
- Debiopharm International · 30 trials · 17% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Scripps Health · 23% recruiting · 30 trials
- Hugo W. Moser Research Institute at Kennedy Krieger · 23% recruiting · 73 trials
- Texas A&M University · 23% recruiting · 95 trials
- Chugai Pharmaceutical · 24% recruiting · 17 trials
Related
What to do with this Major Extremity Trauma Research Consortium page
30 registered trials is a research-attention snapshot, not an endorsement of Major Extremity Trauma Research Consortium or any single study.
- 7 of Major Extremity Trauma Research Consortium's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Post Operative Surgical Site Infection is the condition Major Extremity Trauma Research Consortium studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post Operative Surgical Site Infection trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Major Extremity Trauma Research Consortium pipeline card: 30 registered trials from official public datasets.Report a data error.